Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Clin Pharmacol Ther. 2020 May 31;108(5):1010–1017. doi: 10.1002/cpt.1885

Figure 1.

Figure 1.

Outcome occurrence rate ratios and 95% confidence intervals for the association between the risk of serious bleeding and concomitant use of sulfonylureas or metformin in warfarin users

Serious bleeding: a composite outcome of gastrointestinal bleeding and non-traumatic intracranial hemorrhage